Thus far in the calendar year 2025, the stock price of GSK Pharma has zoomed 40 per cent, as against 1.8 per cent rise in BSE ...

A complaint against GSK accusing it of a major breach of the pharma industry's code of practice on prescribing information has been upheld after a review by the Prescription Medicines Code of ...

The South African Communist Party (SACP) in the Western Cape has learnt that several employees who work for Glaxo Smith Kline (GSK) pharmaceutical company based in Epping, Cape Town, have tested ...

At close: April 17 at 3:30:01 PM GMT+5:30 ...

In pharmaphorum's Digital and social media themed month, Daniel Ghinn explores GSK's use of social media and the milestones it has reached to achieve its current success in this space. "There's a ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 47,591.24 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

GSK’s Blenrep combos are being reviewed in 14 nations. Credit: Magda Wygralak/Shutterstock. The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorised GSK’s Blenrep for ...

17th Apr 2025 7:10 am RNS Arexvy now ACIP recommended for 50-59 at risk 17th Apr 2025 7:05 am RNS GSK 5-in-1 meningitis vaccine recommended in US 17th Apr 2025 7:00 am RNS Transaction in Own Shares ...

GlaxoSmithKline Pharmaceuticals Limited is a subsidiary of UK-based GSK Plc., a global biopharma company to unite science, technology and talent to get ahead of disease together. The Company is ...